News

Suominen Corporation Reports Q2 2025: Challenges and Recovery

Suominen Corporation Reports Q2 2025: Challenges and Recovery

Suominen Corporation’s Financial Overview for Q2 2025

Suominen Corporation recently provided its financial report for the period of January 1 to June 30, 2025. The company faced significant challenges due to a fluctuating trade environment and ongoing operational changes. With its new CEO Charles Héaulmé set to begin in mid-August 2025, the company is focused on improving profitability and sustainability.

Key Highlights for April–June 2025

In the second quarter of 2025, Suominen recorded a notable decrease in net sales by 16%, which fell to EUR 99.8 million compared to the same period in 2024. Comparable EBITDA also dropped to EUR 3.2 million from EUR 5.0 million the previous year. Cash flow from operations was considerably negative at EUR -10.1 million.

First Half Performance Summary

The first half of 2025 reported net sales of EUR 217.3 million, representing a 6% decline from 2024. Comparable EBITDA for this period was EUR 7.3 million, a decrease from EUR 9.5 million. The cash flow from operations showed a negative trend again at EUR -10.5 million.

Market Challenges and Strategic Actions

During the second quarter, the market saw volatility primarily due to tariff changes affecting trade dynamics, especially with nonwoven products. To combat these challenges, Suominen initiated a cost-saving program targeting approximately EUR 10 million in savings. This involved the reduction of around 60 positions globally and the implementation of other efficiency measures.

Investment Progress and Leadership Changes

The ongoing investment initiatives in Spain are progressing well, and efforts continue to ramp up operations from the Bethune facility in the USA. The recent changes in leadership, with Janne Silonsaari stepping in as interim CEO, are part of a strategic pivot to enhance the company’s performance.

Q2 2025 Financial Performance Summary

For the second quarter, key figures indicate that net sales and profit margins have suffered due to market conditions. Sales in the Americas accounted for EUR 59.9 million while EMEA generated EUR 40 million. Currency fluctuations negatively affected net sales by approximately EUR 3.6 million across all regions.

Financial Position and Future Outlook

As of the end of June 2025, Suominen reported net interest-bearing liabilities amounting to EUR 86.8 million, with a gearing ratio of 85.5%, compared to 47.9% in the previous year. Nevertheless, Suominen anticipates that its comparable EBITDA for the full year 2025 will improve from 2024 levels, presuming stabilization in the global market.

Investment and Sustainability Initiatives

The gross capital expenditure for the first half totaled EUR 11.7 million, focusing on growth investments in both the USA and Spain. Suominen remains committed to sustainable production practices, targeting reductions in greenhouse gas emissions in alignment with international climate objectives.

Corporate Governance and Future Communications

Suominen’s governance structures remain robust, ensuring accountability and transparency in operations. The company invites stakeholders to stay updated through its official channels as it prepares to release its next financial outlook soon.

Frequently Asked Questions

What was Suominen's net sales for Q2 2025?

Suominen's net sales for Q2 2025 were EUR 99.8 million, a decrease of 16% from the previous year.

How did the leadership change impact the company?

The leadership change is part of Suominen's strategy to navigate through market volatility, with new CEO Charles Héaulmé leading the charge towards improved financial health.

What are the company's sustainability goals?

Suominen aims to reduce greenhouse gas emissions significantly and achieve zero manufacturing waste to landfill by 2030.

How much was the cash flow from operations in H1 2025?

The cash flow from operations for the first half of 2025 was EUR -10.5 million.

What does the future look like for Suominen?

Suominen expects improved comparable EBITDA numbers for 2025, contingent on a stabilizing economic environment and successful cost-saving measures.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

PotlatchDeltic Reveals Tax Implications for 2024 Shareholder Dividends

Updated Category News Views 247

PotlatchDeltic Reveals Dividend Tax Treatment for 2024 PotlatchDeltic Corporation (Nasdaq: PCH) is stepping into the spotlight by announcing the tax treatment for its anticipated dividend distributions throughout the year. As a prominent player in the real estate investment sector, this announcement brings clarity to investors regarding how dividends will be categorized...

Continue Reading
Beyond Air Secures $3.25 Million from Warrant Exercises

Updated Category News Views 158

Beyond Air's Strategic Moves to Boost Capital Beyond Air, Inc. (NASDAQ: XAIR), a leading medical device and biopharmaceutical company, is making waves in the financial realm. Focused on the innovative use of nitric oxide (NO) to enhance patient care, Beyond Air has announced the immediate exercise of certain outstanding warrants, aiming to generate approximately $3.25...

Continue Reading
Dr. Sven Kili Joins Saisei Ventures as New Partner

Updated Category News Views 194

Saisei Ventures Welcomes Dr. Sven Kili as Partner Saisei Ventures, a prominent investment firm focused on the advancement of biotechnology and therapeutic innovations, has announced an exciting new chapter in its journey. Dr. Sven Kili, MD, has been appointed as a partner, marking a significant addition to the team's leadership. Dr. Kili, who played an advisory role since...

Continue Reading
MangoRx Unveils Innovative Tirzepatide Tablet for Weight Loss

Updated Category News Views 192

Mangoceuticals, Inc. (NASDAQ: MGRX) launched its new oral Tirzepatide tablet, TRIM, back in 2024 at a steep price of $399 per month. Traders noticed this shift towards a convenient alternative to traditional injectables and were already debating the long-term implications on sales and market share. TRIM's Role: A Game Changer for Weight Management? Tirzepatide has made...

Continue Reading
Mama’s Creations Q2 FY2025 Earnings Call Announcement

Updated Category News Views 77

Mama’s Creations to Host Earnings Call for Second Quarter FY2025 Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, is preparing to announce its financial results for the fiscal second quarter, which ended on July 31. The earnings call is scheduled to take place after the market closes on September 10....

Continue Reading